1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, July 2019

Biotechnology Analysis & Statistics in the United States, July 2019

Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

  • All
    • Global Markets Direct

All regions

1-30 of about 900 reports

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 - Pipeline Review, H1 2019

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 - Pipeline Review, H1 2019SummaryCarcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen ...

  • Industries : Therapy, Cancer, Pathology, Medical Biotechnology, Pharmaceutical, Oncology
  • Countries : World, United States
C-X-C Chemokine Receptor Type 4 - Pipeline Review, H1 2019

C-X-C Chemokine Receptor Type 4 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • May 2019

C-X-C Chemokine Receptor Type 4 - Pipeline Review, H1 2019SummaryC-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide ...

  • Industries : Cancer, Therapy, Medical Biotechnology, Pathology, Pharmaceutical
  • Countries : United States
C-X-C Chemokine Receptor Type 2 - Pipeline Review, H1 2019

C-X-C Chemokine Receptor Type 2 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • May 2019

C-X-C Chemokine Receptor Type 2 - Pipeline Review, H1 2019SummaryC-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 ...

  • Industries : Medical Biotechnology, Therapy, Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Cancer
  • Countries : World, United States
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2019

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2019SummaryCytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen ...

  • Industries : Therapy, Medical Biotechnology, Oncology, Cancer, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : United States, World
Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019SummaryTumo ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Therapy, Pharmaceutical
  • Countries : United States, World
Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H1 2019

Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 ...

  • Industries : Therapy, Medical Biotechnology, Cancer, Pathology
  • Countries : United States
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2019

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2019SummaryInterleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen ...

  • Industries : Therapy, Pharmaceutical, Pathology, Cancer, Medical Biotechnology
  • Countries : World, United States
T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H1 2019

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H1 2019SummaryAccording to the recently published report ’T Cell Surface Glycoprotein ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Therapy, Pharmaceutical
  • Countries : World, United States
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2019

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2019SummaryC-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) ...

  • Industries : Therapy, Pathology, Pharmaceutical, Medical Biotechnology
  • Countries : United States, World
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019SummaryAlpha Synuclein (Non A Beta Component Of AD Amyloid or Non ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : United States
Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H1 2019

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H1 2019SummaryRespiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Respiratory syncytial virus G protein ...

  • Industries : Therapy, Pharmaceutical, Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : World, United States
5’ Nucleotidase (Ecto 5’ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Pipeline Review, H1 2019

5’ Nucleotidase (Ecto 5’ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

5’ Nucleotidase (Ecto 5’ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Pipeline Review, H1 2019Summary5’ Nucleotidase (Ecto 5’ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) pipeline Target constitutes ...

  • Industries : Therapy, Pharmaceutical, Medical Biotechnology, Cancer, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeline Review, H1 2019

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog ...

  • Industries : Therapy, Oncology, Medical Biotechnology
  • Countries : World, United States, Australia
Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H1 2019

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H1 2019SummaryIntegrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Integrin beta-3 (?3) o ...

  • Industries : Therapy, Pharmaceutical, Pathology, Medical Biotechnology
  • Countries : United States
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Survival Motor Neuron Protein - Pipeline Review, ...

  • Industries : Therapy, Pharmaceutical, Mental Health
  • Countries : United States, World
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019

  • $ 2500
  • Company report
  • April 2019

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney ...

  • Industries : Pathology, Healthcare, Pharmaceutical
  • Countries : United States
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • May 2019

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections ...

  • Industries : Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States
Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2019

Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • May 2019

Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Granulomatosis with Polyangiitis ...

  • Industries : Therapy, Medical Biotechnology, Pharmaceutical, Pathology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
Grass Pollen Allergy - Pipeline Review, H1 2019

Grass Pollen Allergy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • May 2019

Grass Pollen Allergy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Grass Pollen Allergy - Pipeline Review, H1 2019, provides an ...

  • Industries : Chronic Disease, Pathology, Medical Biotechnology, Biotechnology, Pharmaceutical
  • Countries : United States
Diabetic Nephropathy - Pipeline Review, H1 2019

Diabetic Nephropathy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • May 2019

Diabetic Nephropathy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Pipeline Review, H1 2019, provides an ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, Australia, Australasia, World
Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2019

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Systemic Sclerosis (Scleroderma) - Pipeline Review, ...

  • Industries : Pathology, Chronic Disease, Healthcare, Therapy, Pharmaceutical
  • Countries : United States
Nasopharyngeal Cancer - Pipeline Review, H1 2019

Nasopharyngeal Cancer - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Nasopharyngeal Cancer - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngeal Cancer - Pipeline Review, H1 2019, provides an ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical
  • Countries : United States, North America
Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2019

Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Crohn’s Disease (Regional Enteritis) - Pipeline ...

  • Industries : Pathology, Healthcare, Pharmaceutical
  • Countries : United States
Arrhythmias - Pipeline Review, H1 2019

Arrhythmias - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Arrhythmias - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Arrhythmias - Pipeline Review, H1 2019, provides an overview of the Arrhythmias ...

  • Industries : Therapy, Chronic Disease, Pharmaceutical, Pathology, Medical Biotechnology
  • Countries : United States, World
Sepsis - Pipeline Review, H1 2019

Sepsis - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Sepsis - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Sepsis - Pipeline Review, H1 2019, provides an overview of the Sepsis (Infectious ...

  • Industries : Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States
Synovial Sarcoma - Pipeline Review, H1 2019

Synovial Sarcoma - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Synovial Sarcoma - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Synovial Sarcoma - Pipeline Review, H1 2019, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States
Bronchopulmonary Dysplasia - Pipeline Review, H1 2019

Bronchopulmonary Dysplasia - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Bronchopulmonary Dysplasia - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bronchopulmonary Dysplasia - Pipeline Review, H1 2019, ...

  • Industries : Therapy, Pharmaceutical, Medical Biotechnology
  • Countries : United States
Diabetic Macular Edema - Pipeline Review, H1 2019

Diabetic Macular Edema - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Diabetic Macular Edema - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Macular Edema - Pipeline Review, H1 2019, provides ...

  • Industries : Pharmaceutical, Therapy, Medical Biotechnology
  • Countries : United States
Osteoarthritis - Pipeline Review, H1 2019

Osteoarthritis - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Osteoarthritis - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2019, provides an overview of ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States, North America, World, Australia
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2019

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver Disease (NAFLD) ...

  • Industries : Pathology, Healthcare, Pharmaceutical, Therapy
  • Countries : United States

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on